| Literature DB >> 28167771 |
Erika M Kwon1, John P Connelly1, Nancy F Hansen2, Frank X Donovan3, Thomas Winkler4, Brian W Davis5, Halah Alkadi1, Settara C Chandrasekharappa3, Cynthia E Dunbar4, James C Mullikin2, Paul Liu6.
Abstract
Genome integrity of induced pluripotent stem cells (iPSCs) has been extensively studied in recent years, but it is still unclear whether iPSCs contain more genomic variations than cultured somatic cells. One important question is the origin of genomic variations detected in iPSCs-whether iPSC reprogramming induces such variations. Here, we undertook a unique approach by deriving fibroblast subclones and clonal iPSC lines from the same fibroblast population and applied next-generation sequencing to compare genomic variations in these lines. Targeted deep sequencing of parental fibroblasts revealed that most variants detected in clonal iPSCs and fibroblast subclones were rare variants inherited from the parental fibroblasts. Only a small number of variants remained undetectable in the parental fibroblasts, which were thus likely to be de novo. Importantly, the clonal iPSCs and fibroblast subclones contained comparable numbers of de novo variants. Collectively, our data suggest that iPSC reprogramming is not mutagenic.Keywords: exome sequencing; fibroblasts; genomic variation; iPSCs; reprogramming
Mesh:
Year: 2017 PMID: 28167771 PMCID: PMC5338363 DOI: 10.1073/pnas.1616035114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205